跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 55 条关于
“NaV1.2”
全部
55
临床试验
16
药物
32
机构
0
资讯
7
去年
FamilieSCN2A and Cellectricon Join Forces to Advance Drug Development for Autism and Epilepsy-Linked SCN2A Gene
去年
Channel Therapeutics' NaV1.7 Inhibitor Shows Promising Results for Ocular Pain in Preclinical Trials
去年
Metrion Biosciences Unveils Breakthrough NaV1.9 Screening Assay to Accelerate Non-Opioid Pain Therapeutics Development
2年前
Novel NaV1.8 Inhibitors Lead Wave of Non-Opioid Pain Treatments as Industry Tackles Opioid Crisis
去年
Quiver Bioscience Names Co-Founder Graham Dempsey CEO to Advance Nav1.7-Targeting ASO for Chronic Pain
3个月前
Suzetrigine: A Novel NaV1.8 Blocker for Acute Pain Shows Promise but Falls Short of Opioid Superiority
2年前
DAV132 Adsorbent Does Not Interfere with Plasma Concentrations of Key Antibiotics